CHRISTOPHER DISCENNA: Open Payments
NPI 1083198246 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,898 in 34 payments from 10 companies in 2025. Trend: 2023 $639 · 2024 $5,123 · 2025 $5,898
Speaker / faculty: $5,000Food & beverage: $609Travel & lodging: $288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $5,439 |
| Tris Pharma Inc | 2 | $141 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
| Axsome Therapeutics, Inc. | 1 | $55 |
| Lundbeck LLC | 3 | $54 |
| Alkermes, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, Dyanavel XR, AUSTEDO XR, Auvelity, REXULTI, FANAPT, VIVITROL, Jornay PM.
Industry payments across MI — which companies pay providers there.
